What schedule classification is Methylphenidate (Ritalin) categorized under for treating ADHD?

Methylphenidate, commonly known by its brand name Ritalin, is classified as a Schedule II controlled substance. This classification reflects its medical use for conditions such as Attention Deficit Hyperactivity Disorder (ADHD) while also acknowledging the potential for abuse and dependency. Schedule II substances are considered to have a high potential for abuse, which may lead to severe psychological or physical dependence.

The classification is significant because it dictates how the medication can be prescribed, dispensed, and monitored. For Schedule II drugs, prescriptions must be written and signed by a physician, and refills are typically not allowed. This highlights the importance of careful management when it comes to medications that can impact the central nervous system and behavior.